A Managed Access Program (MAP) is a healthcare initiative designed to provide access to investigational or unapproved medications for patients with serious or life-threatening conditions. MAPs are developed in partnership with healthcare providers, regulatory bodies, and pharmaceutical companies. These programs address the urgent medical requirements of people who have exhausted all therapeutic choices. Patients can receive the drugs under close supervision, and data gathered during the study could help with future research and regulatory choices. MAPs offer equal and controlled access to potentially helpful pharmaceuticals while ensuring patient safety and regulatory compliance.